The patent EP3612550C0 was granted to Glaxosmithkline on Jun 18, 2025 following the initial filing on Apr 18, 2018 under the application number
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents